Portefeuille d'ETF XPH (NYSE) - Page 3 | MetaTrader

Afficher le graphique complet Full chart

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

OMER Omeros Corp 3.85 M 224.04 K 1.67%

ARVN Arvinas Inc 3.84 M 323.44 K 1.67%

CRMD CorMedix Inc 3.79 M 325.52 K 1.65%

TRVI Trevi Therapeutics Inc 3.79 M 302.35 K 1.65%

AMPH Amphastar Pharmaceuticals Inc 3.77 M 140.77 K 1.64%

PAHC Phibro Animal Health Corp 3.72 M 99.66 K 1.62%

WVE WaVe Life Sciences Ltd 3.60 M 211.78 K 1.57%

OCUL Ocular Therapeutix Inc 3.38 M 278.02 K 1.47%

NKTR Nektar Therapeutics 3.14 M 74.20 K 1.36%

AQST Aquestive Therapeutics Inc 3.01 M 465.93 K 1.31%

ZVRA Zevra Therapeutics Inc 2.61 M 291.73 K 1.14%

ELVN Enliven Therapeutics Inc 2.49 M 161.59 K 1.08%

Ventyx Biosciences Inc 2.26 M 249.90 K 0.98%

LENZ LENZ Therapeutics Inc 2.22 M 138.67 K 0.96%

EOLS Evolus Inc 2.22 M 333.16 K 0.96%

SEPN Septerna Inc 2.16 M 77.30 K 0.94%

TBPH Theravance Biopharma Inc 1.96 M 104.55 K 0.85%

CORT Corcept Therapeutics Inc 1.75 M 50.22 K 0.76%

ALMS Alumis Inc 736.42 K 75.45 K 0.32%

State Street Global Advisors 83.02 K 83.02 K 0.04%

1
2
3

Nouvelles

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

Pourquoi l'action d'Amneal Pharmaceuticals augmente-t-elle aujourd'hui ? | Benzinga France

Why Is Amneal Pharmaceuticals Stock Gaining Today? - Amneal Pharmaceuticals (NASDAQ:AMRX)

Defensive Stocks: A Potential Antidote To Inflation Shocks

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies